SSM Health Connected Primary Care and Ophthalmology Using LumineticsCore Autonomous AI
SSM Health identified the need for an effective solution to make sure their patients with diabetes complete their annual diabetic retinopathy exam. As leaders in innovation, SSM health chose to integrate LumineticsCore, the first FDA-cleared autonomous AI system for diabetic retinopathy detection in 2023. Through the use of LumineticsCore, SSM Health has been able to provide over 11,000 diabetic retinopathy exams, increasing testing rates for patients and improving collaboration with ophthalmologists when disease is diagnosed, and a referral is needed.
70x Increase in Exams
After integrating LumineticsCore, SSM Health saw a 70x increase in the number of diabetic retinopathy exams performed in the first year.
View the SSM Health Customer Case Study
Notice: The content embedded within PDF files on this website ("Content") is provided solely for educational purposes. Digital Diagnostics ("Owner") holds exclusive rights to the Content, including but not limited to copyrights, trademarks, and any other intellectual property rights.